Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions
Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions
The purpose of this study is to demonstrate the relative bioavailability of Nadolol (1 x 80
 mg) tablets under fasting conditions.
Inclusion Criteria:

 -  No clinically significant abnormal finding on physical exam, medical history, or
 clinical laboratory results on screening.

 Exclusion Criteria:

 -  Positive test results for HIV or hepatitis B or C.

 -  Treatment for drug or alcohol dependence.